UnitedHealth Group Incorporated (UNH) Stock Analysis
Breakout setup
Healthcare · Healthcare Plans
Sell if holding. Analyst target reached at $408.78 — A.R:R is negative (-1.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (1.8% away).
UnitedHealth Group operates two segments: UnitedHealthcare (health benefits for ~47M members across employer, Medicare, and Medicaid programs) and Optum (care delivery for 95M consumers, $31.1B Optum Insight backlog, Optum Rx managing $188B pharmaceutical spend). Revenue is ~80%... Read more
Sell if holding. Analyst target reached at $408.78 — A.R:R is negative (-1.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (1.8% away). Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Score 4.9/10, moderate confidence.
Passes 5/8 gates (positive momentum, clean insider activity, earnings proximity 33d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and news legal. Suitability: moderate.
Recent developments
updated 2026-06-13Recent Developments — UnitedHealth Group Incorporated
Latest news
- NEWS Mark Cuban Pushes 'Service Level Agreements' For Healthcare, Warns Failed Policies Should End — benzinga Jun 15, 2026 neutral
- NEWS Patients Denied Care, Then Approved Later? Federal Watchdog Raises Medicare Advantage Concerns — benzinga Jun 11, 2026 negative
- NEWS 7 Health Care Stocks With Whale Alerts In Today's Session — benzinga Jun 9, 2026 neutral
- NEWS Mizuho Maintains Outperform on UnitedHealth Group, Raises Price Target to $460 — benzinga Jun 8, 2026 positive
- NEWS AbbVie, UnitedHealth, Sabra Health Care And A Consumer Defensive Stock On CNBC's 'Final Trades' — benzinga Jun 8, 2026 neutral
Generated 2026-06-15T18:11:47Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerCMS44%10-K Item 1: 'Premium revenues from CMS represented 44% of UnitedHealth Group’s total consolidated revenues for the year ended December 31, 2025'
Material Events(8-K, last 90d)
- 2026-03-02Item 5.02LOWOn Feb 24, 2026, Dennis Stankiewicz was appointed Chief Accounting Officer of UnitedHealth Group, effective March 2, 2026. He continues as Corporate Controller, a role held since April 2023. Base salary set at $550,000.SEC filing →
- 2026-02-25Item 5.02LOWOn Feb 23, 2026, the Compensation Committee amended Stephen Hemsley's stock option (granted May 14, 2025) to add a two-year holding requirement for net shares acquired upon exercise. All other terms unchanged.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $408.78 — A.R:R is negative (-1.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Near 52-week high (1.8% away). Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Prior stop was $389.00. Score 4.9/10, moderate confidence.
Take-profit target: $407.66 (-0.2% upside). Prior stop was $389.00. Stop-loss: $389.00.
Analyst target reached - limited upside remaining; Near 52-week high (1.8% away); Weak overall score: 4.9/10.
UnitedHealth Group Incorporated trades at a P/E of 30.8 (forward 19.5). TrendMatrix value score: 4.9/10. Verdict: Sell.
34 analysts cover UNH with a consensus score of 3.9/5. Average price target: $407.
What does UnitedHealth Group Incorporated do?UnitedHealth Group operates two segments: UnitedHealthcare (health benefits for ~47M members across employer, Medicare,...
UnitedHealth Group operates two segments: UnitedHealthcare (health benefits for ~47M members across employer, Medicare, and Medicaid programs) and Optum (care delivery for 95M consumers, $31.1B Optum Insight backlog, Optum Rx managing $188B pharmaceutical spend). Revenue is ~80% risk-based premiums; CMS premiums represented 44% of consolidated revenues in 2025.